LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.

Hilton LK, Gillis S, Y-Moayyed F, Bridgers J, Alduaij W, Jiang A, Ben-Neriah S, Collinge B, Wong JCH, Boyle M, Meissner B, Slack GW, Farinha P, Craig JW, Gerrie AS, Villa D, Savage KJ, Sehn LH, Karsan A, Wright GW, Staudt LM, Morin RD, Steidl C, Scott DW

Open source

DOI: 10.1182/bloodadvances.2026020105
Published: 2026 Jun 23
Container: Blood advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2026020105,
  title = {LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.},
  author = {Hilton LK and Gillis S and Y-Moayyed F and Bridgers J and Alduaij W and Jiang A and Ben-Neriah S and Collinge B and Wong JCH and Boyle M and Meissner B and Slack GW and Farinha P and Craig JW and Gerrie AS and Villa D and Savage KJ and Sehn LH and Karsan A and Wright GW and Staudt LM and Morin RD and Steidl C and Scott DW},
  year = {2026},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2026020105},
  url = {https://doi.org/10.1182/bloodadvances.2026020105}
}

RIS

TY  - JOUR
TI  - LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.
AU  - Hilton LK
AU  - Gillis S
AU  - Y-Moayyed F
AU  - Bridgers J
AU  - Alduaij W
AU  - Jiang A
AU  - Ben-Neriah S
AU  - Collinge B
AU  - Wong JCH
AU  - Boyle M
AU  - Meissner B
AU  - Slack GW
AU  - Farinha P
AU  - Craig JW
AU  - Gerrie AS
AU  - Villa D
AU  - Savage KJ
AU  - Sehn LH
AU  - Karsan A
AU  - Wright GW
AU  - Staudt LM
AU  - Morin RD
AU  - Steidl C
AU  - Scott DW
PY  - 2026
JO  - Blood advances
DO  - 10.1182/bloodadvances.2026020105
UR  - https://doi.org/10.1182/bloodadvances.2026020105
ER  -

APA

LK, H., S, G., F, Y., J, B., W, A., A, J., S, B., B, C., JCH, W., M, B., B, M., GW, S., P, F., JW, C., AS, G., D, V., KJ, S., LH, S., A, K., GW, W., LM, S., RD, M., C, S., & DW, S. (2026). LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.. Blood advances. https://doi.org/10.1182/bloodadvances.2026020105

Source records

pubmed · retrieved 2026-11-10T12:00:47.013Z